Role of physical activity in GLP-1 receptor agonist therapy for obesity treatment

Role of physical activity in GLP-1 receptor agonist therapy for obesity treatment

Introduction: WHO recognized it as a global obesity crisis. Globally there are 2,5 billion adult people living with excess body weight (43% of global adult population). Out of these 890 million have obesity disease (16% of global adult population). This forces to implement safe and effective body m...

Full description

Saved in:
Bibliographic Details
Main Authors: Łukasz Zdziebkowski, Hanna Wilska, Dorota Szatkowska, Dominika Ziętara, Kacper Kmieć, Aleksandra Topolska, Marcin Komorowski, Michał Janiszewski, Natalia Surosz, Michał Grochowalski, Aleksandra Graczyk, Jakub Szydło
Format: Article
Language:English
Published: Nicolaus Copernicus University in Toruń 2025-07-01
Series:Quality in Sport
Subjects:
GLP-1 receptor agonist
obesity treatment
Liraglutide
Semaglutide
Tirzepatide
weight loss
Online Access:https://apcz.umk.pl/QS/article/view/62342
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items